Metformin improves cognitive impairment in patients with schizophrenia: associated with enhanced functional connectivity of dorsolateral prefrontal cortex

Cognitive impairment is a core feature of schizophrenia, which is aggravated by antipsychotics-induced metabolic disturbance and lacks effective pharmacologic treatments in clinical practice. Our previous study demonstrated the efficiency of metformin in alleviating metabolic disturbance following a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Tiannan, Huang, Jing, Zhao, Yuxin, Wang, Weiyan, Tian, Xiaohan, Hei, Gangrui, Kang, Dongyu, Gao, Yong, Liu, Fangkun, Zhao, Jingping, Liu, Bing, Yuan, Ti-Fei, Wu, Renrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567690/
https://www.ncbi.nlm.nih.gov/pubmed/37821461
http://dx.doi.org/10.1038/s41398-023-02616-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567690/
https://www.ncbi.nlm.nih.gov/pubmed/37821461
http://dx.doi.org/10.1038/s41398-023-02616-x

Ejemplares similares